uric acid has been researched along with Hepatitis C in 4 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Total cholesterol, high- and low-density lipoprotein cholesterol, triglyceride, fasting blood glucose and uric acid were determined, and hepatitis B serum antigen (HBsAg) and anti-HCV antibodies were assayed using commercial kits." | 3.79 | Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age. ( Chen, IC; Chiu, FH; Chuang, CH; Lee, YY; Li, WC; Sun, C, 2013) |
| "Uric acid elevation was reported in many systemic diseases and might be elevated during direct antiviral therapy." | 1.56 | Efficacy of antiviral therapy in patients with post-hepatitis C liver cirrhosis: is hyperuricaemia a potential adverse effect? ( Abbas, A; Elsayed, A; Hassan, H; Hassnine, A; M Abdelraheem, E, 2020) |
| "In addition, a single patient with von Gierke's disease showed a marked increase in the plasma activity of this enzyme, relative to that apparent in normal subjects." | 1.29 | Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography. ( Higashino, K; Hiroishi, K; Moriwaki, Y; Nasako, Y; Takahashi, S; Tsutsumi, Z; Yamakita, J; Yamamoto, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elsayed, A | 1 |
| M Abdelraheem, E | 1 |
| Hassan, H | 1 |
| Abbas, A | 1 |
| Hassnine, A | 1 |
| Li, WC | 1 |
| Lee, YY | 1 |
| Chen, IC | 1 |
| Sun, C | 1 |
| Chiu, FH | 1 |
| Chuang, CH | 1 |
| Vlatkovic, V | 1 |
| Trbojevic-Stankovic, J | 1 |
| Stojimirovic, B | 1 |
| Yamamoto, T | 1 |
| Moriwaki, Y | 1 |
| Takahashi, S | 1 |
| Tsutsumi, Z | 1 |
| Yamakita, J | 1 |
| Nasako, Y | 1 |
| Hiroishi, K | 1 |
| Higashino, K | 1 |
4 other studies available for uric acid and Hepatitis C
| Article | Year |
|---|---|
Efficacy of antiviral therapy in patients with post-hepatitis C liver cirrhosis: is hyperuricaemia a potential adverse effect?
Topics: Antiviral Agents; Child; Hepacivirus; Hepatitis C; Humans; Hyperuricemia; Liver Cirrhosis; Prospecti | 2020 |
Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age.
Topics: Adult; Age Distribution; Age Factors; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cr | 2013 |
Malnutrition-inflammation complex syndrome and hepatitis C in maintenance hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Creatinine; Femal | 2009 |
Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Ethanol; Glycogen Storage Disease Type I; Gout; Heparin; Hepat | 1996 |